PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono TOKYO, April 25, 2024 /PRNewswire/ — PRISM BioLab, Co. Ltd. (“PRISM”), a leading…

  

By

Leave a Reply

Your email address will not be published. Required fields are marked *